Nationwide Fund Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-169
| Closed | -$33K | – | 3247 |
|
|
2017
Q1 | $33K | Sell |
169
-39
| -19% | -$7.62K | ﹤0.01% | 3039 |
|
|
2016
Q4 | $56K | Hold |
208
| – | – | ﹤0.01% | 2995 |
|
|
2016
Q3 | $82K | Hold |
208
| – | – | ﹤0.01% | 2952 |
|
|
2016
Q2 | $72K | Sell |
208
-250
| -55% | -$86.5K | ﹤0.01% | 3017 |
|
|
2016
Q1 | $381K | Buy |
458
+8
| +2% | +$6.66K | ﹤0.01% | 2231 |
|
|
2015
Q4 | $471K | Buy |
450
+298
| +196% | +$312K | ﹤0.01% | 2148 |
|
|
2015
Q3 | $120K | Hold |
152
| – | – | ﹤0.01% | 2824 |
|
|
2015
Q2 | $201K | Buy |
152
+59
| +63% | +$78K | ﹤0.01% | 2708 |
|
|
2015
Q1 | $189K | Sell |
93
-3
| -3% | -$6.1K | ﹤0.01% | 2718 |
|
|
2014
Q4 | $185K | Buy |
96
+8
| +9% | +$15.4K | ﹤0.01% | 2674 |
|
|
2014
Q3 | $72K | Buy |
88
+3
| +4% | +$2.46K | ﹤0.01% | 3059 |
|
|
2014
Q2 | $82K | Buy |
85
+18
| +27% | +$17.4K | ﹤0.01% | 3055 |
|
|
2014
Q1 | $72K | Hold |
67
| – | – | ﹤0.01% | 2819 |
|
|
2013
Q4 | $59K | Hold |
67
| – | – | ﹤0.01% | 3050 |
|
|
2013
Q3 | $76K | Sell |
67
-3
| -4% | -$3.4K | ﹤0.01% | 2997 |
|
|
2013
Q2 | $83K | Buy |
+70
| New | +$83K | ﹤0.01% | 2855 |
|